TY  - JOUR
AU  - Cañete, Fiorella
AU  - Mañosa, Míriam
AU  - Perez-Martinez, Isabel
AU  - Barreiro-de-Acosta, Manuel
AU  - Gonzalez-Sueyro, Ramiro C
AU  - Nos, Pilar
AU  - Iglesias-Flores, Eva
AU  - Gutierrez, Ana
AU  - Bujanda, Luis
AU  - Gordillo, Jordi
AU  - Rios-Leon, Raquel
AU  - Casanova, Maria Jose
AU  - Villoria, Albert
AU  - Rodriguez-Lago, Iago
AU  - Lopez-Serrano, Pilar
AU  - Garcia-Herola, Antonio
AU  - Ramirez-de-la-Piscina, Patricia
AU  - Navarro-Llavat, Merce
AU  - Taxonera, Carlos
AU  - Barrio, Jesus
AU  - Ramos, Laura
AU  - Navarro, Pablo
AU  - Benitez-Leiva, Olga
AU  - Calafat, Margalida
AU  - Domenech, Eugeni
PY  - 2020
DO  - 10.14309/ctg.0000000000000218
UR  - https://hdl.handle.net/10668/27949
T2  - Clinical and translational gastroenterology
AB  - Patients with Crohn's disease experiencing endoscopic postoperative recurrence (POR) may benefit from antitumor necrosis factor (TNF) agents but scarce data on this are available. Our aim was to assess the efficacy of anti-TNF in improving mucosal...
LA  - en
PB  - Wolters Kluwer Health
KW  - Anti-Inflammatory Agents
KW  - Colonoscopy
KW  - Crohn Disease
KW  - Immunosuppressive Agents
KW  - Intestinal Mucosa
KW  - Recurrence
KW  - Retrospective Studies
KW  - Adalimumab
KW  - Adolescent
KW  - Adult
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Infliximab
KW  - Male
KW  - Mercaptopurine
KW  - Propensity Score
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - Young Adult
TI  - Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
TY  - research article
VL  - 11
ER  -